Biology subjects

Gutman, B. A.

Publications and source records attributed to Gutman, B. A..

5 recordsLinked to original sources

bioRxiv2026

Machine learning on subcortical brain features: A study of sample size efficiency for neurodegenerative disease classification

Subcortical brain alterations are a key feature of dementia disease progression. Machine learning (ML) has been applied widely to MRI-based brain features in dementia, where performance depends on the model choice, training data size, and input feature characteristics. Most studies compare ML models using a single training sample size. Here, we evaluate the sample-size efficiency of ML models based on subcortical gross volume and vertex-wise shape features for dementia stage classification using 2,511 samples in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Learning curves were generated for dementia vs. cognitively normal controls (CN), dementia vs. mild cognitive impairment (MCI), and MCI vs. CN across increasing training sample sizes. Classification performance improved when increasing sample size for all models, with late- fusion models consistently achieving the highest performance, and Logit-TVL1 outperforming the other shape-based models. Learning curve analysis showed that classification performance was driven by the training sample size and the magnitude of anatomical group differences, and can be used to optimize future model selection tasks in dementia and other brain disorders.

neuroscience↗

bioRxiv2026

A 3D Brain Geometry Toolkit for Multisite Neuroimaging Analysis

Compared to traditional gross volumetrics, surface-based models provide greater spatial precision for understanding brain alterations related to developmental, neurological, and psychiatric disorders. Large-scale brain initiatives are combining data from around the world to discover and improve illness-related brain markers. Here, we present a toolkit for 3D brain geometry analysis aimed at addressing key challenges facing large-scale neuroimaging studies. Our framework incorporates scalable methods for multisite data integration, site-specific confound correction, accelerated statistical modeling, interpretable machine learning, and interactive results visualization. The toolkit was tested on data from 21 independently collected study samples participating in the ENIGMA Bipolar Disorder Working Group (N = 3,373). Compared to traditional volume features, we show how subcortical shape measures can be combined across study sites to capture spatially complex differences between diagnostic groups and associations with common treatments. Statistical modeling was accelerated using the Fast and Efficient Mixed-Effects Algorithm (FEMA) and achieved a 16-fold reduction in computation time compared to traditional approaches. Machine learning models showed shape features may provide greater predictive performance over traditional volumes for both diagnostic and treatment prediction tasks, with interpretable weight maps providing insights into the local features driving model performance.

neuroscience↗

bioRxiv2024

A Surface-based deep learning approach for cortical shape analysis

Advances in deep learning hold promise for predicting clinical factors from human brain images. In this study, we applied a spherical harmonics-based convolutional neural network approach (SPHARM-Net) to MRI-derived brain shape metrics to predict age, sex, and Alzheimers disease (AD) diagnosis. MRI-derived brain features included vertex-wise cortical curvature, convexity, thickness, and surface area. SPHARM-Net performs convolutions using the spherical harmonic transforms, eliminating the need to explicitly define neighborhood size, and achieving rotational equivariance. Sex classification and age regression were carried out in a large sample of healthy adults (UK Biobank; N=32,979), and AD classification performance was tested in a large, publicly available sample (ADNI; N=1,213). SPHARM-Net showed strong performance for sex classification (accuracy=0.91; balanced accuracy= 0.91; AUC=0.97), and age regression (average absolute error=2.97 years; R-squared=0.77; Pearsons coefficient=0.9). AD classification also performed well (accuracy=0.86; balanced accuracy=0.83; AUC=0.9). Our experiments demonstrate promising preliminary performance using the SPHARM-Net for two widely studied benchmarking tasks and for AD classification. Future work will include comparisons of shape-based methods and extending these analysis to more challenging tasks such as mood disorder classification.

neuroscience↗

bioRxiv2018

Deep Learning for Quality Control of Subcortical Brain 3D Shape Models

We present several deep learning models for assessing the morphometric fidelity of deep grey matter region models extracted from brain MRI. We test three different convolutional neural net architectures (VGGNet, ResNet and Inception) over 2D maps of geometric features. Further, we present a novel geometry feature augmentation technique based on parametric spherical mapping. Finally, we present an approach for model decision visualization, allowing human raters to see the areas of subcortical shapes most likely to be deemed of failing quality by the machine. Our training data is comprised of 5200 subjects from the ENIGMA Schizophrenia MRI cohorts, and our test dataset contains 1500 subjects from the ENIGMA Major Depressive Disorder cohorts. Our final models reduce human rater time by 46-70%. ResNet outperforms VGGNet and Inception for all of our predictive tasks.

neuroscience↗

bioRxiv2017

Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging

As very large studies of complex neuroimaging phenotypes become more common, human quality assessment of MRI-derived data remains one of the last major bottlenecks. Few attempts have so far been made to address this issue with machine learning. In this work, we optimize predictive models of quality for meshes representing deep brain structure shapes. We use standard vertex-wise and global shape features computed homologously across 19 cohorts and over 7500 human-rated subjects, training kernelized Support Vector Machine and Gradient Boosted Decision Trees classifiers to detect meshes of failing quality. Our models generalize across datasets and diseases, reducing human workload by 30-70%, or equivalently hundreds of human rater hours for datasets of comparable size, with recall rates approaching inter-rater reliability.

neuroscience↗